Drug Search Results
More Filters [+]

Acamprosate

Alternative Names: acamprosate, campral
Latest Update: 2024-12-17
Latest Update Note: Clinical Trial Update

Product Description

Acamprosate is used along with counseling and social support to help people who have stopped drinking large amounts of alcohol (alcoholism) to avoid drinking alcohol again.

Mechanisms of Action: MGLUR5 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Austria | Belgium | Brazil | Canada | Chile | Colombia | Czech | Denmark | France | Germany | India | Ireland | Italy | Japan | Korea | Lebanon | Luxembourg | Netherlands | Norway | Peru | Poland | Portugal | Serbia | Slovakia | South Africa | Spain | Sweden | Switzerland | Taiwan | Turkey | United Kingdom | United States | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Acamprosate

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events